137 related articles for article (PubMed ID: 18541689)
41. Monitoring drug safety in Astrakhan, Russia.
Kirilochev OO; Dorfman IP; Umerova AR
Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
[TBL] [Abstract][Full Text] [Related]
42. Hospital pharmacists' knowledge and opinions regarding adverse drug reaction reporting in Northern China.
Su C; Ji H; Su Y
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):217-22. PubMed ID: 20033911
[TBL] [Abstract][Full Text] [Related]
43. Multidisciplinary program for detecting and evaluating adverse drug reactions.
Keith MR; Bellanger-McCleery RA; Fuchs JE
Am J Hosp Pharm; 1989 Sep; 46(9):1809-12. PubMed ID: 2801715
[TBL] [Abstract][Full Text] [Related]
44. Reporting adverse drug reactions is everyone's business: an adverse drug reaction reporting program that works.
Burkhardt ME; Ripepe SD
Top Hosp Pharm Manage; 1992 Jul; 12(2):31-9. PubMed ID: 10128727
[TBL] [Abstract][Full Text] [Related]
45. Pharmacy-coordinated, multidisciplinary adverse drug reaction program.
Swanson KM; Landry JP; Anderson RP
Top Hosp Pharm Manage; 1992 Jul; 12(2):49-59. PubMed ID: 10136574
[TBL] [Abstract][Full Text] [Related]
46. Recording previous adverse drug reactions--a gap in the system.
Shenfield GM; Robb T; Duguid M
Br J Clin Pharmacol; 2001 Jun; 51(6):623-6. PubMed ID: 11422023
[TBL] [Abstract][Full Text] [Related]
47. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions.
Tyler LS; Nickman NA
Am J Hosp Pharm; 1992 Apr; 49(4):845-50. PubMed ID: 1595720
[TBL] [Abstract][Full Text] [Related]
48. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
Ramesh M; Pandit J; Parthasarathi G
Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
[TBL] [Abstract][Full Text] [Related]
49. Implementation of a module to promote competency in adverse drug reaction reporting in undergraduate medical students.
Tripathi RK; Jalgaonkar SV; Sarkate PV; Rege NN
Indian J Pharmacol; 2016 Oct; 48(Suppl 1):S69-S73. PubMed ID: 28031613
[TBL] [Abstract][Full Text] [Related]
50. Pattern of adverse drug reactions experienced by tuberculosis patients in a tertiary care teaching hospital in Western Nepal.
P V K; Palaian S; Ojha P; P R S
Pak J Pharm Sci; 2008 Jan; 21(1):51-6. PubMed ID: 18166520
[TBL] [Abstract][Full Text] [Related]
51. Founding an adverse drug reaction (ADR) network: a method for improving doctors spontaneous ADR reporting in a general hospital.
Goldstein LH; Berlin M; Saliba W; Elias M; Berkovitch M
J Clin Pharmacol; 2013 Nov; 53(11):1220-5. PubMed ID: 23852627
[TBL] [Abstract][Full Text] [Related]
52. How to promote adverse drug reaction reports using information systems - a systematic review and meta-analysis.
Ribeiro-Vaz I; Silva AM; Costa Santos C; Cruz-Correia R
BMC Med Inform Decis Mak; 2016 Mar; 16():27. PubMed ID: 26926375
[TBL] [Abstract][Full Text] [Related]
53. Multidisciplinary adverse drug reaction surveillance program.
Prosser TR; Kamysz PL
Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
[TBL] [Abstract][Full Text] [Related]
54. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
56. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
Ball D; Tisócki T
Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
[TBL] [Abstract][Full Text] [Related]
57. A survey of adverse drug reaction reporting programs in select hospitals.
Case RL; Guzzetti PJ
Hosp Pharm; 1986 May; 21(5):423-6, 431-4, 438. PubMed ID: 10276799
[TBL] [Abstract][Full Text] [Related]
58. Detection of adverse drug reactions through the minimum basic data set.
Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E
Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432
[TBL] [Abstract][Full Text] [Related]
59. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands.
van der Hooft CS; Sturkenboom MC; van Grootheest K; Kingma HJ; Stricker BH
Drug Saf; 2006; 29(2):161-8. PubMed ID: 16454543
[TBL] [Abstract][Full Text] [Related]
60. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital.
Jose J; Rao PG; Kamath MS; Jimmy B
J Altern Complement Med; 2009 Jul; 15(7):793-7. PubMed ID: 19534607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
